Shizuoka Cancer Center Hospital and Research Institute ( Site 0802)
Sunto Gun, Shizuoka, Japan
Cancer treatment center in Nagaizumi
1007 Shimonagakubo, Nagaizumi, Sunto District, Shizuoka 411-8777
About Shizuoka Cancer Center Hospital and Research Institute ( Site 0802)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Shizuoka Cancer Center Hospital and Research Institute ( Site 0802)
During the past decade, Shizuoka Cancer Center Hospital and Research Institute ( Site 0802) conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pilot Study in Patients With Symptomatic Steroid-Naive Asthma
2001-08-01
2003-02-01
Completed
120
Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis
2002-03-01
2004-01-01
Completed
210
An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
Completed
Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
2003-04-01
2006-07-01
Completed
150
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
2002-05-01
2003-01-01
Completed
445
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
2002-12-01
2003-06-01
Completed
386
Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)
2004-07-01
2004-12-01
Completed
686
Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
2004-10-01
Completed
300
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Shizuoka Cancer Center Hospital and Research Institute ( Site 0802)
According to Clinical.Site data, the most researched conditions in "Shizuoka Cancer Center Hospital and Research Institute ( Site 0802)" are
"Carcinoma, Non-squamous Non-small-cell Lung" (1 trials), "Carcinoma, Squamous Cell, Non-small-cell Lung" (1 trials), "Gastric Cancer" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Shizuoka Cancer Center Hospital and Research Institute ( Site 0802)" in a lesser frequency.
Clinical Trials Intervention Types at Shizuoka Cancer Center Hospital and Research Institute ( Site 0802)
Most popular intervention types in "Shizuoka Cancer Center Hospital and Research Institute ( Site 0802)" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Olaparib" (2 trials), "Pembrolizumab" (2 trials), "Capecitabine" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Shizuoka Cancer Center Hospital and Research Institute ( Site 0802)
The vast majority of trials in "Shizuoka Cancer Center Hospital and Research Institute ( Site 0802)" are
4 trials for "All" genders.
Clinical Trials Status at Shizuoka Cancer Center Hospital and Research Institute ( Site 0802)
Currently, there are NaN active trials in "Shizuoka Cancer Center Hospital and Research Institute ( Site 0802)".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Shizuoka Cancer Center Hospital and Research Institute ( Site 0802),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Shizuoka Cancer Center Hospital and Research Institute ( Site 0802), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".